WHO issues new guidelines for gene editing; Doudna-backed Caribou launches its first allogeneic CAR-T trial
Three years after news of the birth of two gene-edited babies shocked ethicists, regulators and biologists around the world, World Health Organization experts called for the establishment of a new whistle-blowing mechanism to help prevent future unsafe or unethical uses of CRISPR and other gene editing technologies.
The recommendation was one of a series the WHO panel issued Monday in a pair of reports designed to guide global governance of gene editing. The panel was convened in December 2018, weeks after Chinese scientist He Jiankui announced two babies were born from embryos he edited, and follows a similar effort from the International Commission on the Clinical Use of Human Germline Genome Editing, which released a series of recommendations last year.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.